'Cuddle Hormone' May Help Curb Symptoms of Prader-Willi Syndrome

by Sheela Philomena on  June 25, 2011 at 11:05 AM Child Health News   - G J E 4
The hormone oxytocin shows promising results in Prader-Willi syndrome condition. Prader-Willi syndrome is a rare genetic disorder which affects one child in 25,000. Children born with this syndrome have a range of complex neurological and developmental problems which continue into adult life. These can manifest as cognitive and behavioral difficulties, weight gain, problems in controlling their temper and attendant difficulties in socialization. The hormone improves trust, mood and reduces disruptive behavior in Prader-Willi syndrome condition. The research published in the journal Orphanet Journal of Rare Diseases.
 'Cuddle Hormone' May Help Curb Symptoms of Prader-Willi Syndrome
'Cuddle Hormone' May Help Curb Symptoms of Prader-Willi Syndrome

Oxytocin is a key hormone in building social interactions and empathy. It has been shown that taking oxytocin can improve the ability of both healthy and autistic people to read faces and recognize emotion in others. Since Prader-Willi syndrome shares some characteristics with autism, and is also associated with a reduction in the number of oxytocin producing neurons, researchers from France enrolled people at a dedicated centre on a trial testing the use of the hormone.

Patients involved in the trial often stayed at the centre for one month visits where they took part in daily occupational and physical activities. They also received medical care and psychological support if it was needed. During one of their usual visits the patients received a single dose of either oxytocin, or placebo, and their eating and behavior monitored for two days prior to the treatment, and two days after.

Professor Tauber from Centre de R'f'rence du Syndrome de Prader-Willi, France, said, "Two days after administration of oxytocin, we noticed that our patients had increased trust, decreased sadness and showed less disruptive behavior. Despite the small size of our trial, a single dose of oxytocin had a significant, late acting, effect on our patients. This is really encouraging news for the continued management of people with Prader-Willi syndrome."

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

More News on: